196 related articles for article (PubMed ID: 16690483)
21. Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components.
Sarkaria IS; Zakowski MF; Pham D; Hezel M; Ebright MI; Chuai S; Venkatraman ES; Kris MG; Rusch VW; Singh B
Ann Thorac Surg; 2008 Jan; 85(1):216-23. PubMed ID: 18154814
[TBL] [Abstract][Full Text] [Related]
22. An immunohistochemical analysis of antioxidant and glutathione S-transferase enzyme levels in normal and neoplastic human lung.
Coursin DB; Cihla HP; Sempf J; Oberley TD; Oberley LW
Histol Histopathol; 1996 Oct; 11(4):851-60. PubMed ID: 8930626
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical analysis of p53 mutations in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma.
Wang X; Rao MS; Yeldandi AV
Mod Pathol; 1995 Dec; 8(9):919-23. PubMed ID: 8751332
[TBL] [Abstract][Full Text] [Related]
24. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society.
Xu L; Tavora F; Battafarano R; Burke A
Am J Surg Pathol; 2012 Feb; 36(2):273-82. PubMed ID: 22198010
[TBL] [Abstract][Full Text] [Related]
25. Increased cytoplasmic S100A6 expression is associated with pulmonary adenocarcinoma progression.
Ishii A; Suzuki M; Satomi K; Kobayashi H; Sakashita S; Kano J; Pei Y; Minami Y; Ishikawa S; Noguchi M
Pathol Int; 2009 Sep; 59(9):623-30. PubMed ID: 19712129
[TBL] [Abstract][Full Text] [Related]
26. Comparison of extracellular matrix antigens in subtypes of bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma. An immunohistochemical study.
Ohori NP; Yousem SA; Griffin J; Stanis K; Stetler-Stevenson WG; Colby TV; Sonmez-Alpan E
Am J Surg Pathol; 1992 Jul; 16(7):675-86. PubMed ID: 1326898
[TBL] [Abstract][Full Text] [Related]
27. MMP-2 activation and stepwise progression of pulmonary adenocarcinoma: analysis of MMP-2 and MMP-9 with gelatin zymography.
Iijima T; Minami Y; Nakamura N; Onizuka M; Morishita Y; Inadome Y; Noguchi M
Pathol Int; 2004 May; 54(5):295-301. PubMed ID: 15086833
[TBL] [Abstract][Full Text] [Related]
28. Papillary adenocarcinoma of the lung is a more advanced adenocarcinoma than bronchioloalveolar carcinoma that is composed of two distinct histological subtypes.
Jian Z; Tomizawa Y; Yanagitani N; Iijima H; Sano T; Nakajima T
Pathol Int; 2005 Oct; 55(10):619-25. PubMed ID: 16185291
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathology of stromal invasion in lung adenocarcinoma.
Fujita A; Kameda Y; Goya T
Pathol Int; 2009 Jan; 59(1):1-6. PubMed ID: 19121086
[TBL] [Abstract][Full Text] [Related]
30. Neutrophils promote aerogenous spread of lung adenocarcinoma with bronchioloalveolar carcinoma features.
Wislez M; Antoine M; Rabbe N; Gounant V; Poulot V; Lavolé A; Fleury-Feith J; Cadranel J
Clin Cancer Res; 2007 Jun; 13(12):3518-27. PubMed ID: 17575214
[TBL] [Abstract][Full Text] [Related]
31. Different estrogen receptor beta expression in distinct histologic subtypes of lung adenocarcinoma.
Alì G; Donati V; Loggini B; Servadio A; Dell'Omodarme M; Prati MC; Camacci T; Lucchi M; Melfi F; Mussi A; Fontanini G
Hum Pathol; 2008 Oct; 39(10):1465-73. PubMed ID: 18620727
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary adenocarcinomas: classification and reporting.
Kerr KM
Histopathology; 2009 Jan; 54(1):12-27. PubMed ID: 19187177
[TBL] [Abstract][Full Text] [Related]
33. Lung adenocarcinoma with a micropapillary pattern: a clinicopathological study of 25 cases.
Kuroda N; Hamaguchi N; Takeuchi E; Ohara M; Hirouchi T; Mizuno K
APMIS; 2006 May; 114(5):381-5. PubMed ID: 16725015
[TBL] [Abstract][Full Text] [Related]
34. Prognostic analysis of pulmonary adenocarcinoma subclassification with special consideration of papillary and bronchioloalveolar types.
Aida S; Shimazaki H; Sato K; Sato M; Deguchi H; Ozeki Y; Tamai S
Histopathology; 2004 Nov; 45(5):468-76. PubMed ID: 15500650
[TBL] [Abstract][Full Text] [Related]
35. [The new classification of lung adenocarcinoma].
Petersen I
Zentralbl Chir; 2013 Oct; 138 Suppl 1():S16-24. PubMed ID: 24150851
[TBL] [Abstract][Full Text] [Related]
36. Expression of aquaporin 3 (AQP3) in normal and neoplastic lung tissues.
Liu YL; Matsuzaki T; Nakazawa T; Murata S; Nakamura N; Kondo T; Iwashina M; Mochizuki K; Yamane T; Takata K; Katoh R
Hum Pathol; 2007 Jan; 38(1):171-8. PubMed ID: 17056099
[TBL] [Abstract][Full Text] [Related]
37. Surfactant protein A detection in primary pulmonary adenocarcinoma without bronchioloalveolar pattern.
Uzaslan E; Stuempel T; Ebsen M; Freudenberg N; Nakamura S; Costabel U; Guzman J
Respiration; 2005; 72(3):249-53. PubMed ID: 15942293
[TBL] [Abstract][Full Text] [Related]
38. New pathologic classification of lung cancer: relevance for clinical practice and clinical trials.
Travis WD; Brambilla E; Riely GJ
J Clin Oncol; 2013 Mar; 31(8):992-1001. PubMed ID: 23401443
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological characteristics of subcentimeter adenocarcinomas of the lung.
Kato F; Hamasaki M; Miyake Y; Iwasaki A; Iwasaki H; Nabeshima K
Lung Cancer; 2012 Sep; 77(3):495-500. PubMed ID: 22727683
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation in small lung adenocarcinoma with bronchioloalveolar carcinoma components.
Kubo T; Yamamoto H; Ichimura K; Jida M; Hayashi T; Otani H; Tsukuda K; Sano Y; Kiura K; Toyooka S
Lung Cancer; 2009 Sep; 65(3):328-32. PubMed ID: 19144441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
